Photo by Jafar Ahmed on Unsplash
PainReform Ltd. (NASDAQ: PRFX) CEO Ilan Hadar spoke at Benzinga’s All Access: Stocks.
Hadar discussed PainReform’s proprietary therapeutics for non-opiate, post-surgical pain relief as well as the industry’s market size and the …
Full story available on Benzinga.com